Literature DB >> 3018185

Pituitary adenomas in patients under 20 years old. A clinicopathological study of 12 cases.

K Mukai, E L Seljeskog, L P Dehner.   

Abstract

The clinical manifestations, pathological features and follow-up data on 12 cases of pituitary adenoma in patient less than 20 years old were evaluated. This group represented 8.5% of our 142 cases of pituitary adenoma from all age groups during the period of study. There were five males and seven females whose ages ranged from 13 to 19 years at diagnosis. Immunocytochemical staining demonstrated the presence of prolactin in 10 tumors, ACTH in one tumor and the remaining neoplasm was negative for the five major pituitary hormones (prolactin, hGH, ACTH, TSH, gonadotrophin). The results of the immunocytochemistry correlated appropriately with the clinical manifestations. Extension beyond the sella turcica at presentation was a common feature as evidenced by the high incidence of visual defects (75%). A complete excision was accomplished in only two patients. The aggressive behavior of these tumors was demonstrated by a recurrence rate of 50% and only a single long-term cure. Early detection and therapy, if possible, are essential for the successful management of pituitary adenomas in younger patients as implied by our study and other reports in the literature.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018185     DOI: 10.1007/bf02158007

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  34 in total

1.  Pituitary adenomas of adolescents.

Authors:  H Ortiz-Suarez; D L Erickson
Journal:  J Neurosurg       Date:  1975-10       Impact factor: 5.115

2.  Pituitary microadenomas in children.

Authors:  C Di Rocco; G Maira; P Borrelli
Journal:  Childs Brain       Date:  1982

Review 3.  Epidemiology of pituitary adenomas.

Authors:  E B Gold
Journal:  Epidemiol Rev       Date:  1981       Impact factor: 6.222

4.  Pituitary apoplexy: its incidence and clinical significance.

Authors:  S Wakai; T Fukushima; A Teramoto; K Sano
Journal:  J Neurosurg       Date:  1981-08       Impact factor: 5.115

Review 5.  Histological classification of pituitary disease.

Authors:  S L Asa; K Kovacs
Journal:  Clin Endocrinol Metab       Date:  1983-11

Review 6.  Pituitary adenomas. An update on their management with an emphasis on the role of bromocriptine.

Authors:  D L Barrow; G T Tindall
Journal:  J Clin Neuroophthalmol       Date:  1983-12

7.  Bromocriptine reduces the size of cells in prolactin-secreting pituitary adenomas.

Authors:  A M Landolt; H Minder; V Osterwalder; T A Landolt
Journal:  Experientia       Date:  1983-06-15

8.  Pituitary adenomas. Immunocytochemical study of 150 tumors with clinicopathologic correlation.

Authors:  K Mukai
Journal:  Cancer       Date:  1983-08-15       Impact factor: 6.860

9.  Parasellar tumors in children. I. Clinical presentation, preoperative assessment, and differential diagnosis.

Authors:  I L Richmond; C B Wilson
Journal:  Childs Brain       Date:  1980

10.  A pituitary parasellar tumor with extracranial metastases and high, partially suppressible levels of adrenocorticotropin and related peptides.

Authors:  F E Kaiser; D N Orth; K Mukai; J H Oppenheimer
Journal:  J Clin Endocrinol Metab       Date:  1983-09       Impact factor: 5.958

View more
  1 in total

Review 1.  Gene therapy for pituitary tumors.

Authors:  Adriana Seilicovich; Daniel Pisera; Sandra A Sciascia; Marianela Candolfi; Mariana Puntel; Weidong Xiong; Gabriela Jaita; Maria G Castro
Journal:  Curr Gene Ther       Date:  2005-12       Impact factor: 4.391

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.